Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura G, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Lin A, Racagni G, Altamura CA.

Eur Neuropsychopharmacol. 2000 Mar;10(2):119-24.

PMID:
10706993
2.

Serotonin-immune interactions in detoxified chronic alcoholic patients without apparent liver disease: activation of the inflammatory response system and lower plasma total tryptophan.

Maes M, Lin A, Bosmans E, Vandoolaeghe E, Bonaccorso S, Kenis G, De Jongh R, Verkerk R, Song C, Scharpé S, Neels H.

Psychiatry Res. 1998 May 8;78(3):151-61.

PMID:
9657419
3.

Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor.

Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Altamura CA.

Schizophr Res. 2002 Apr 1;54(3):281-91.

PMID:
11950553
4.

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.

Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, Berghmans R, Stans G, Desnyder R.

Schizophr Res. 1996 Jul;21(1):39-50.

PMID:
8998275
5.

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

Lin A, Kenis G, Bignotti S, Tura GJ, De Jong R, Bosmans E, Pioli R, Altamura C, Scharpé S, Maes M.

Schizophr Res. 1998 Jun 22;32(1):9-15.

PMID:
9690329
6.

Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events.

Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E.

Biol Psychiatry. 1999 Apr 1;45(7):833-9.

PMID:
10202570
7.

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H.

Cytokine. 1997 Nov;9(11):853-8.

PMID:
9367546
8.

Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.

Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY.

J Psychiatr Res. 1995 Mar-Apr;29(2):141-52.

PMID:
7666381
9.

Immunological differences between patients with major depression and somatization syndrome.

Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M.

Psychiatry Res. 2001 Dec 31;105(3):165-74.

PMID:
11814536
10.

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.

Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M.

Eur Neuropsychopharmacol. 2001 Jun;11(3):203-8.

PMID:
11418279
11.

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.

Maes M, Meltzer HY, Bosmans E.

Acta Psychiatr Scand. 1994 May;89(5):346-51.

PMID:
8067274
12.
13.

The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines.

Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E, Neels H.

Psychoneuroendocrinology. 1999 May;24(4):371-83.

PMID:
10341365
14.

Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.

Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E.

Eur J Endocrinol. 2000 Aug;143(2):197-202.

15.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
16.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
17.

In vivo immunomodulatory effects of clozapine in schizophrenia.

Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY.

Schizophr Res. 1997 Aug 29;26(2-3):221-5.

PMID:
9323354
18.

Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.

Ritsner M, Perelroyzen G, Ilan H, Gibel A.

J Clin Psychopharmacol. 2004 Jun;24(3):245-54.

PMID:
15118477
19.
20.

Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF.

Neuroendocrinology. 2007;85(4):249-56. Epub 2007 Jun 15.

PMID:
17570902
Items per page

Supplemental Content

Write to the Help Desk